Sovaldi and P-gp inducers co-administration contraindicated
Sovaldi (sofosbuvir; Gilead) should not be co-administered with moderate P-gp inducers because this may reduce plasma concentration of sofosbuvir, according to the updated summary of product characteristics.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200781
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com